Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROS-2: Testosterone Dose-Response on Prostate
NCT01327495Phase 3Completed
- Sponsor
- University of Washington
- Start
- Oct 2011
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Testosterone TEPI patch in Hypogonadism, sponsored by University of Washington. Started Oct 2011; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT01327495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01327495.